Blog 2

Contact lenses for kids – paediatric, parent and practitioner psychology

By Kate Gifford | October 12, 2018 | 0 Comments

When selecting an optical treatment for myopia management, contact lens options appear to be the most consistent, with OrthoK and multifocal soft contact lenses offering around a 50% efficacy for controlling refractive and axial change in myopia.1 And it’s not just the important benefit of modifying lifelong risk of vision impairment through successful myopia control which should be top of mind – contact lens wear for myopic children can offer significant immediate benefits to their self-perception and satisfaction with vision correction.

Contact lens safety in kids

By Kate Gifford | June 29, 2018 | 1 Comment

A key barrier to contact lens wear in children is parental and practitioner concern about safety. The research indicates, though, that children may be the safest contact lens wearers – here we describe the statistics and how to approach clinical communication.

Myopia management message part 2 – efficacy

By Kate Gifford | June 26, 2018 | 0 Comments

Let’s cut to the chase – until further notice, you can consider low dose (0.05%) atropine, soft multifocal CL’s and OrthoK as all quite similar in terms of their myopia control efficacy, being around 50% on average. A network meta-analysis of sixteen different interventions studied for myopia control showed these options to all have similar efficacy when their refractive and axial length outcomes were put on a level playing field.

Myopia management message part 1 – expectations

By Kate Gifford | June 26, 2018 | 0 Comments

We have a convincing evidence base for several optical, one pharmacological and visual environment solutions to reduce the progression of childhood myopia, but nothing guarantees 100% efficacy. Because of this, even in when under a successful myopia management strategy, a child’s myopia may still progress.

How myopic dioptres are like IOP

By Kate Gifford | June 25, 2018 | 0 Comments

Higher IOP dioptres means more risk of pathology and vision impairment, but it’s not guaranteed for an individual, Read more here…

The ‘why’ of myopia control

By Kate Gifford | June 25, 2018 | 0 Comments

It is commonly understood that myopia prevalence is growing globally. By 2050, it is predicted that half of the world’s population – five billion people – will be myopic, with nearly one billion at risk of myopia related ocular pathology. The late Brien Holden was a champion of ensuring myopia is placed on the world health agenda – high myopia is strongly linked to higher risk of cataract, retinal detachment and myopic maculopathy, and increasing rates of vision impairment and blindness due to the latter are already evident in Asian countries.

ARVO 2018 – Part 1

By Kate Gifford | June 24, 2018 | 0 Comments

The annual Association for Research in Vision and Ophthalmology (ARVO) conference moved off mainland America to Hawaii for the first time in May 2018.

ARVO 2018 – Part 2

By Kate Gifford | June 24, 2018 | 0 Comments

With over 10,000 attendees and thousands of research posters, papers and symposiums presented over 5 days, it was a mind blowing nerdy extravaganza. Here are a bunch of cutting edge research pieces which I posted to the Myopia Profile Facebook group at the time.

ARVO 2018 – Part 3

By Kate Gifford | June 24, 2018 | 0 Comments

Discover the latest research from the annual Association for Research in Vision and Ophthalmology (ARVO) conference. Find our more in our part 3 article.

International Myopia Conference 2017 Part 1

By Kate Gifford | June 24, 2018 | 0 Comments

The session topics covered prevalence, progression and risk factors of myopia, mechanisms such as light exposure and visual pathways, optical and pharmacological methods of myopia control, genetics, clinical trial considerations, myopic eye shape and accommodation and binocularity.